Evolv Sole Source Document Deceives Customers

Published Jan 30, 2023 13:44 PM

Evolv was brought into several Baltimore City Public Schools this year on a one-semester pilot program, but a sole source document signed by Evolv's CEO touting Evolv's capabilities contains multiple deceptive claims.

IPVM Image

In this report, IPVM examines the document, obtained via a public records request, as well as the false claims it contains and the company's pilot in Baltimore City Public Schools.

**********

********* **** ******* ***** ******** *** Evolv ***** **** ******. *** ******** told **** ** "***********" *** *********** ** ******* ************* *********** * ****-****** ****** (********** the ******** **** *****).

**** ******* *** *** ********** ****** a **** ****** ******. ***** *** district *** ******** **** ****** *********, it ********** ***** ** ********* *** procurement ** ******* ******** ** ********* by ***** ****** ***, ************** ********** DJA-RA, *** ***** ***.

*** ***** *** ********* ****** *** 2nd ******** (***** **** **** *****) ** **** ********* **** **** schools:

*** ***** *** ******* **** ** consultation **** ******* ** ***** *** stakeholders. ** *** ****** **** *********** planning ****** **** ***** *********** ********* **** ****** ********** *** ********.

Evolv ********

*** ********, ********** *** * ****** records *******, *** **** ** *** school ******** *** ****** ** ***** CEO ***** ****** ** **** *, 2022, ******** ******** *****/********** ******.

IPVM Image

"*** ****** **** ***** *********"

***** *** ********** **** **** ********* in ***********, ******** ** ** **********. Evolv *** ***** ** ***** **** its ******** ********* "*** ******" **************** ***** *********.

"************ *********"

*****'* ********* ** ******** *** "************," ** ***** ** ** ******* of*** ******* ******** *****, **** ************* *** ******** *****, **** ******** ***** *** **** Evolv ***** ******** *** *******.

***** **** **** ******** **** *** have ** ***** **** ** *******.*** **** ** ******, ** ** is **** ********** **** ******** **** to ***** **** ** ****** *****, **** ** ***********, ** **** through *** ******** ******* ********** ** alarm.

"*** ******** ***** ****"

**** ** **** *********. ******* **** year, ****'* ****** ** ******* ********************** ** ******* ***** ***** ***** of *-**%. ********, ***** *** *** ******* the ******* **** **** ****** *** range.

********* ******** *** ** **** (******** Public *********** ***) ******* ****** ****, in **** *********** ******,********'* ********** ****** ******** ******** **,*** alerts ** ***,*** ***** ******** *******(~**% ***** ****).

*** ** ***** **,*** ******, **** 123 ****** **** ********** ** *** district ** "******** *******." **** ** equivalent ** * **** ***** *** of *** ******.

IPVM Image

************,**** *** ******** ***** ** ** actual ***************** * **% ***** ***** ****—** 26 ***** ****** *** ** *** people ********.

Evolv ********

***** *** *** ******* ** ****'* direct ********* ***** *** ********** ****** in *** **** ****** ********. *******, the ******* ****** * ******* *********:

** ** **** **** ******, ** discuss *** ************ *** *********** ** the ******* ****** **** *********, *********, and ******* ******** *************. *** ********* posed ** ********* ** ********* *** addressed ******** ** *** *************** ****** the ******* *** ***** *****, *** in ***** ** ********. ****** *** me **** ** ***’* **** ** to ******* *** **** * ******** directly.

2-Day ****** '*****'

** ******* *****, ** *********'************* ******** ********* **** ******,*** ********* **** *** **** ** early ******, *** ****** *** ******* school ****. *************** ****** ********, ***** *** ****** ** *******, has ******** ** ********* ** ****.

****** ******** *** * ****** ******* request **** * *** **** ********, the **********, ******** ** **** ***** 30 ******* ** ******** ** *** Evolv ******* ****** ***** "***** ** welcome ********" (*** *** *** *** aware ******** **** *** ********* ****** yet).

IPVM Image

** *********** ***** *** ***** ******—*********** settings, ********* *****, ***** ******, ********, etc., *** ******** ** *** ****** or *******.

Schools: '******** ******* *******'

********* **** ******* **** **** **** reviewed "******* *******" ********** ***** ** Evolv "******* *****."

********* **** ****** ******* (**** *******) reviewed ******* ******* ** **** ******** and ******* *** ******** ** *** students, ***** *** *******. ***** ******* consideration, ** ***** ** ******* * limited ***** ** *** ***** ********** at **** ******* ** *** ****** semester ** *** ****-**** ****** ****. The ******** **** *** **** ******** and * ******** ***'* ** **** on * **** ********-**** ************** ***** after *** ***** ** *********.

Utica ********

*** ******** ***** *****'* ************* *** warranted. ** ******* **** ** *****-******** Proctor **** ****** ** *****, **, a **-****-*** ******* ******* ** **-****-*** classmate ******** *****. *****, *** ** sensitivity ******* "*", *** *********** ** the ****** ** *** *** ** the ********,****** ************** ***** ***** **** ****. ********, ***** ***** **** ***** "recommended" ******* *** ***** ******* ** this *******. ***** ***** *** ******* on ****.

***** *** *** *********** ********, "*" through "*", **** "*" ***** *** most *********. ******* "*" ** *** most ****** **** *** ******* "*" is *** ****** **** ****, ** IPVM's ******** *****. *** * **** detailed**** ****** ** ***** *********** ********.

***** ** ******* "*" *** *********** problems ********* ******, ****** ******* ****** **** * **% detection ****. ******* "*" *** **** *****, as *** ****** ********* ** ****.

***** **** **** **** ***** ** "*** *** ******* ******** *** *******" *** ********* **** *** $* million ***** ****** *** **** *******.

Kennywood ********

** ********* **,* ****** **** **** ********* *****-******** ********* ***** **** ******* of **********.******** ** *** ************* * ******* *** ********* ** police ** *** *****.

*******, ****** ***** ****** ***** *** shooting, ****** ***** **** *** ********* many *** ******* ** *** ***** and *** *******(*) ****** ** *****.

Comments (2)
U
Undisclosed #1
Jan 30, 2023

*** *** ******* ****** ******** (****** William ******, **) ********* ** ***** $10-15M *** **** ****. *** **** "deadly" ******** **** **** ** ***** before **** ******* ** **** *** of *********?

****** ******* ****** *********** *******-********* ******* for ******, **** ******* | **** | ******************.***

U
Undisclosed #2
Jan 30, 2023

* ** ***? **** ******* ******* to ** * ********* ********* *** end *****.

IPVM Image